CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $1.06M invested in Can-Fite BioPharma in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$507K
2
+$31.5K
3
+$4.82K

Top Sellers

1
-$81.5K
2
-$44.2K
3
-$1.03K
4
TWC
TD Waterhouse Canada
Ontario, Canada
-$54
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$850K
2
$124K
3
$41K
4
$31.5K
5
$6.66K
6
$4.82K
7
$1.25K
8
$1.23K
9
–
10
–
11
–